Immunotherapy has emerged as a promising approach in the treatment of Myasthenia Gravis (MG), a chronic autoimmune disorder characterized by muscle weakness and fatigue. By harnessing the power of the immune system, immunotherapy aims to modulate or suppress the abnormal immune response that leads to the destruction of acetylcholine receptors.
One of the key immunotherapy strategies used in MG...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian